News reporting that Pfizer denied access to Paxlovid for an independent trial. The press release indicates that Pfizer has denied access for multiple groups1. Also see2.
1.
ANTICOV, Pfizer blocking research to generate evidence on optimal use of novel antiviral for COVID-19 patients in low- and middle-income countries, Press Release, anticov.org/press-releases/2022/pfizer-blocking-research-to-generate-evidence-on-optimal-use-of-novel-antiviral-for-covid-19-patients-in-low-and-middle-income-countries/.
Ledford et al., 4 Apr 2022, preprint, 2 authors.
DOI record:
{
"DOI": "10.1038/d41586-022-00919-5",
"ISSN": [
"0028-0836",
"1476-4687"
],
"URL": "http://dx.doi.org/10.1038/d41586-022-00919-5",
"alternative-id": [
"CM20270880"
],
"author": [
{
"affiliation": [],
"family": "Ledford",
"given": "Heidi",
"sequence": "first"
},
{
"affiliation": [],
"family": "Maxmen",
"given": "Amy",
"sequence": "additional"
}
],
"container-title": [
"Nature"
],
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
4,
4
]
],
"date-time": "2022-04-04T18:03:38Z",
"timestamp": 1649095418000
},
"deposited": {
"date-parts": [
[
2022,
4,
4
]
],
"date-time": "2022-04-04T18:12:47Z",
"timestamp": 1649095967000
},
"indexed": {
"date-parts": [
[
2022,
4,
4
]
],
"date-time": "2022-04-04T18:42:17Z",
"timestamp": 1649097737983
},
"is-referenced-by-count": 0,
"issn-type": [
{
"type": "print",
"value": "0028-0836"
},
{
"type": "electronic",
"value": "1476-4687"
}
],
"issued": {
"date-parts": [
[
2022,
4,
4
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.springer.com/tdm",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
4,
4
]
],
"date-time": "2022-04-04T00:00:00Z",
"timestamp": 1649030400000
}
},
{
"URL": "https://www.springer.com/tdm",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
4,
4
]
],
"date-time": "2022-04-04T00:00:00Z",
"timestamp": 1649030400000
}
}
],
"link": [
{
"URL": "https://www.nature.com/articles/d41586-022-00919-5.pdf",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.nature.com/articles/d41586-022-00919-5",
"content-type": "text/html",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.nature.com/articles/d41586-022-00919-5.pdf",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "297",
"original-title": [],
"prefix": "10.1038",
"published": {
"date-parts": [
[
2022,
4,
4
]
]
},
"published-online": {
"date-parts": [
[
2022,
4,
4
]
]
},
"publisher": "Springer Science and Business Media LLC",
"reference": [
{
"DOI": "10.1056/NEJMoa2118542",
"author": "J. Hammon",
"doi-asserted-by": "publisher",
"journal-title": "N. Engl. J. Med.",
"key": "CM20270880_CR1",
"unstructured": "Hammon, J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2118542 (2022).",
"year": "2022"
}
],
"reference-count": 1,
"references-count": 1,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.nature.com/articles/d41586-022-00919-5"
}
},
"score": 1,
"short-container-title": [
"Nature"
],
"short-title": [],
"source": "Crossref",
"subject": [
"Multidisciplinary"
],
"subtitle": [],
"title": [
"African clinical trial denied access to key COVID drug Paxlovid"
],
"type": "journal-article"
}